Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

FLAIR2 improves LesionTOADS automatic segmentation of multiple sclerosis lesions in non-homogenized, multi-center, 2D clinical magnetic resonance images.

Le M, Tang LYW, Hernández-Torres E, Jarrett M, Brosch T, Metz L, Li DKB, Traboulsee A, Tam RC, Rauscher A, Wiggermann V.

Neuroimage Clin. 2019;23:101918. doi: 10.1016/j.nicl.2019.101918. Epub 2019 Jul 5.

2.

Regulatory T-cells regulate neonatal heart regeneration by potentiating cardiomyocyte proliferation in a paracrine manner.

Li J, Yang KY, Tam RCY, Chan VW, Lan HY, Hori S, Zhou B, Lui KO.

Theranostics. 2019 Jun 9;9(15):4324-4341. doi: 10.7150/thno.32734. eCollection 2019.

3.

Deep learning of joint myelin and T1w MRI features in normal-appearing brain tissue to distinguish between multiple sclerosis patients and healthy controls.

Yoo Y, Tang LYW, Brosch T, Li DKB, Kolind S, Vavasour I, Rauscher A, MacKay AL, Traboulsee A, Tam RC.

Neuroimage Clin. 2017 Oct 14;17:169-178. doi: 10.1016/j.nicl.2017.10.015. eCollection 2018.

4.

Human CLEC16A regulates autophagy through modulating mTOR activity.

Tam RC, Li MW, Gao YP, Pang YT, Yan S, Ge W, Lau CS, Chan VS.

Exp Cell Res. 2017 Mar 15;352(2):304-312. doi: 10.1016/j.yexcr.2017.02.017. Epub 2017 Feb 20.

PMID:
28223137
5.

MicroRNA-155 Mediates Augmented CD40 Expression in Bone Marrow Derived Plasmacytoid Dendritic Cells in Symptomatic Lupus-Prone NZB/W F1 Mice.

Yan S, Yim LY, Tam RC, Chan A, Lu L, Lau CS, Chan VS.

Int J Mol Sci. 2016 Aug 6;17(8). pii: E1282. doi: 10.3390/ijms17081282.

6.

Systemic Lupus Erythematosus Patients Exhibit Reduced Expression of CLEC16A Isoforms in Peripheral Leukocytes.

Tam RC, Lee AL, Yang W, Lau CS, Chan VS.

Int J Mol Sci. 2015 Jun 25;16(7):14428-40. doi: 10.3390/ijms160714428.

7.

Dehydration affects spinal cord cross-sectional area measurement on MRI in healthy subjects.

Wang C, Tam RC, Mackie E, Li DK, Traboulsee AL.

Spinal Cord. 2014 Aug;52(8):616-20. doi: 10.1038/sc.2014.66. Epub 2014 Apr 29.

PMID:
24777158
8.

Fast computation of myelin maps from MRI T₂ relaxation data using multicore CPU and graphics card parallelization.

Yoo Y, Prasloski T, Vavasour I, MacKay A, Traboulsee AL, Li DK, Tam RC.

J Magn Reson Imaging. 2015 Mar;41(3):700-7. doi: 10.1002/jmri.24604. Epub 2014 Feb 27.

PMID:
24578324
9.

B-cell-targeted therapies in systemic lupus erythematosus.

Chan VS, Tsang HH, Tam RC, Lu L, Lau CS.

Cell Mol Immunol. 2013 Mar;10(2):133-42. doi: 10.1038/cmi.2012.64. Epub 2013 Jan 28. Review.

10.

Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis.

Tam RC, Traboulsee A, Riddehough A, Li DK.

Neuroimage Clin. 2012 Sep 5;1(1):29-36. doi: 10.1016/j.nicl.2012.08.004. eCollection 2012.

11.

The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosis.

Tam RC, Traboulsee A, Riddehough A, Sheikhzadeh F, Li DK.

Mult Scler. 2011 Aug;17(8):949-57. doi: 10.1177/1352458511402113. Epub 2011 Apr 18.

PMID:
21502309
12.

Optimizing the use of radiologist seed points for improved multiple sclerosis lesion segmentation.

McAusland J, Tam RC, Wong E, Riddehough A, Li DK.

IEEE Trans Biomed Eng. 2010 Nov;57(11). doi: 10.1109/TBME.2010.2055865.

PMID:
20601307
13.

Detection and measurement of coverage loss in interleaved multi-acquisition brain MRIs due to motion-induced inter-slice misalignment.

Tam RC, Riddehough A, Li DK.

Med Image Anal. 2009 Jun;13(3):381-91. doi: 10.1016/j.media.2008.12.006. Epub 2009 Jan 8.

PMID:
19200772
14.

Safety of unwrapped spherical orbital implants.

Perry JD, Tam RC.

Ophthalmic Plast Reconstr Surg. 2004 Jul;20(4):281-4.

PMID:
15266141
15.

Tolerance to noninherited maternal MHC antigens in mice.

Andrassy J, Kusaka S, Jankowska-Gan E, Torrealba JR, Haynes LD, Marthaler BR, Tam RC, Illigens BM, Anosova N, Benichou G, Burlingham WJ.

J Immunol. 2003 Nov 15;171(10):5554-61.

16.

Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons.

Cheney IW, Lai VC, Zhong W, Brodhag T, Dempsey S, Lim C, Hong Z, Lau JY, Tam RC.

J Virol. 2002 Nov;76(21):11148-54.

17.

Use of electroneurography as a prognostic indicator of Bell's palsy in Chinese patients.

Chow LC, Tam RC, Li MF.

Otol Neurotol. 2002 Jul;23(4):598-601.

PMID:
12170167
18.

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection.

Lau JY, Tam RC, Liang TJ, Hong Z.

Hepatology. 2002 May;35(5):1002-9. Review. No abstract available.

PMID:
11981750
19.

Mechanisms of action of ribavirin in antiviral therapies.

Tam RC, Lau JY, Hong Z.

Antivir Chem Chemother. 2001 Sep;12(5):261-72. Review.

PMID:
11900345
21.

Induction of T-cell response to cryptic MHC determinants during allograft rejection.

Boisgérault F, Anosova NG, Tam RC, Illigens BM, Fedoseyeva EV, Benichou G.

Hum Immunol. 2000 Dec;61(12):1352-62.

PMID:
11163093
22.

Analysis of T-cell response using altered peptide ligands.

Boisgérault F, Anosova N, Fedoseyeva EV, Tam RC, Benichou G.

Methods Mol Biol. 2001;156:211-8. No abstract available.

PMID:
11068762
23.

Synthesis and cytokine modulation properties of pyrrolo[2, 3-d]-4-pyrimidone nucleosides.

Wang G, Tam RC, Gunic E, Du J, Bard J, Pai B.

J Med Chem. 2000 Jun 29;43(13):2566-74.

PMID:
10891116
25.

Monocyclic L-nucleosides with type 1 cytokine-inducing activity.

Ramasamy KS, Tam RC, Bard J, Averett DR.

J Med Chem. 2000 Mar 9;43(5):1019-28.

PMID:
10715165
26.

Inhibition of CD28 expression by oligonucleotide decoys to the regulatory element in exon 1 of the CD28 gene.

Tam RC, Lin CJ, Lim C, Pai B, Stoisavljevic V.

J Immunol. 1999 Oct 15;163(8):4292-9.

28.

Increased potency of an aptameric G-rich oligonucleotide is associated with novel functional properties of phosphorothioate linkages.

Tam RC, Wu-Pong S, Pai B, Lim C, Chan A, Thomas DF, Milovanovic T, Bard J, Middleton PJ.

Antisense Nucleic Acid Drug Dev. 1999 Jun;9(3):289-300.

PMID:
10435754
29.

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

Tam RC, Pai B, Bard J, Lim C, Averett DR, Phan UT, Milovanovic T.

J Hepatol. 1999 Mar;30(3):376-82.

PMID:
10190717
30.

The presentation of self and allogeneic MHC peptides to T lymphocytes.

Benichou G, Malloy KM, Tam RC, Heeger PS, Fedoseyeva EV.

Hum Immunol. 1998 Sep;59(9):540-8. Review.

PMID:
9757910
31.

Indirect T-cell allorecognition: perspectives for peptide-based therapy in transplantation.

Benichou G, Tam RC, Soares LR, Fedoseyeva EV.

Immunol Today. 1997 Feb;18(2):67-71. Review.

PMID:
9057356
32.
33.

The influence of two distinct alloresponse pathways on the design of peptide-based strategies for allograft tolerance.

Benichou G, Tam RC, Soares LR, Popov IA, Garovoy MR, Fedoseyeva EV.

Res Immunol. 1996 Jul-Aug;147(6):377-87. Review. No abstract available.

PMID:
8903104
34.

T cell tolerance is influenced by concomitant T cell recognition of cross-reactive self-peptides.

Tam RC, Fedoseyeva EV, Moskalenko M, Garovoy MR, Benichou G.

J Immunol. 1996 May 15;156(10):3765-71.

PMID:
8621912
35.

Induction of T cell responses to a self-antigen following allotransplantation.

Fedoseyeva EV, Tam RC, Popov IA, Orr PL, Garovoy MR, Benichou G.

Transplantation. 1996 Mar 15;61(5):679-83.

PMID:
8607166
36.

Self determinant selection and acquisition of the autoimmune T cell repertoire.

Benichou G, Tam RC, Orr PI, Garovoy MR, Fedoseyeva EV.

Immunol Res. 1996;15(3):234-45. Review.

PMID:
8902578
38.

Biological availability and nuclease resistance extend the in vitro activity of a phosphorothioate-3'hydroxypropylamine oligonucleotide.

Tam RC, Li Y, Noonberg S, Hwang DG, Lui G, Hunt CA, Garovoy MR.

Nucleic Acids Res. 1994 Mar 25;22(6):977-86.

39.

Nocturnal desaturation and serum erythropoietin: a study in patients with chronic obstructive pulmonary disease and in normal subjects.

Fitzpatrick MF, Mackay T, Whyte KF, Allen M, Tam RC, Dore CJ, Henley M, Cotes PM, Douglas NJ.

Clin Sci (Lond). 1993 Mar;84(3):319-24.

PMID:
8384954
40.

Comparisons of human, rat and mouse erythropoietins by isoelectric focusing: differences between serum and urinary erythropoietins.

Tam RC, Coleman SL, Tiplady RJ, Storring PL, Cotes PM.

Br J Haematol. 1991 Nov;79(3):504-11.

PMID:
1751380
41.

An immunological cross-reactant of erythropoietin in serum which may invalidate EPO radioimmunoassay.

Cotes PM, Tam RC, Reed P, Hellebostad M.

Br J Haematol. 1989 Oct;73(2):265-8.

PMID:
2818943
42.

Sexual dimorphism of erythropoietin-degrading activity in mouse submaxillary gland extracts.

Tam RC, Bedwell J, Cotes PM, Reed PJ.

Exp Hematol. 1989 Feb;17(2):160-3.

PMID:
2912738
43.

Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPD.

Hughes RT, Cotes PM, Oliver DO, Pippard MJ, Royston P, Stevens JM, Strong CA, Tam RC, Winearls CG.

Contrib Nephrol. 1989;76:122-30. No abstract available.

PMID:
2582777
44.

Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.

Egrie JC, Cotes PM, Lane J, Gaines Das RE, Tam RC.

J Immunol Methods. 1987 May 20;99(2):235-41.

PMID:
3584994
45.

Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia.

Wedzicha JA, Cotes PM, Empey DW, Newland AC, Royston JP, Tam RC.

Clin Sci (Lond). 1985 Oct;69(4):413-22.

PMID:
4042542
46.

Serum immunoreactive erythropoietin and erythropoiesis in protein-energy malnutrition.

Wickramasinghe SN, Cotes PM, Gill DS, Tam RC, Grange A, Akinyanju OO.

Br J Haematol. 1985 Jul;60(3):515-24.

PMID:
3925982

Supplemental Content

Support Center